Navigation Links
Vascular Surgeons Agree: Case Rehearsal Improves Outcomes
Date:11/12/2008

CLEVELAND, Ohio and LOD, Israel, November 12 /PRNewswire/ -- Surgeons at the University of Rochester Medical Center, NY indicated that patient-specific CTA data can be converted to an endovascular simulator (ANGIO Mentor(TM), Simbionix US) with high face validity. The surgeons "strongly agreed" that the simulation improved the operative flow, increased patient safety and efficiency of instrument use, decreased overall operative and fluoroscopy time and the amount of contrast used, and that the operative and simulator outcomes were similar.

An abstract of the study is provided below:

Patient Specific Case Rehearsals Using an Endovascular Simulator Prior to Carotid Artery Stenting

Sean J Hislop, MD, Joseph H Hedrick, MD, Michael J Singh, MD, Jeffrey M Rhodes, MD, Joseph P Hart, MD, Marcia Johansson, ACNP, and Karl A Illig, MD

Division of Vascular Surgery, at the Strong Heart and Vascular Center, University of Rochester Medical Center, NY

Objectives: To determine whether a patient's specific carotid anatomy can be modeled using CTA on an endovascular simulator and whether preoperative patient-specific case rehearsal accurately predicts operative experience.

Methods: Patients underwent CTA of the arch and carotid circulation. Simbionix (Cleveland, OH and Lod, Israel) used deidentified CTAs to create simulation files (using PROcedure(TM) Rehersal Studio). The surgeon performed the simulated case within 24 hours of the actual procedure. Likert surveys (strongly agree - strongly disagree) were completed assessing face validity, or the degree to which the simulation mimicked real life.

Results: Five patient-specific simulations were performed. The surgeons "strongly agreed" (median score 5/5) that the simulation improved the operative flow, increased patient safety and efficiency of instrument use, assisted in selection of EPD, stent, diagnostic catheter and balloon, decreased overall operative and fluoroscopy time and the amount of contrast used, and that the operative and simulator outcomes were similar. They "agreed" (median score 4/5) that the simulation assisted with vessel access and with wire selection. Face validity was excellent: surgeons "strongly agreed" that the simulator was easy to use, realistically replicated reality, produced realistic imaging and tactile feedback (haptics), realistically replicated patient arch, carotid and lesion anatomy and that it accurately predicted stent dimensions. All simulated EPD, stent, and balloon dimensions matched those used in the operating room. Subjective observations suggested that the simulation predicted difficulty with vessel cannulation but did not accurately model post-stent deployment changes in bifurcation angulation.

Conclusions: These data indicate that patient-specific CTA-derived data can be converted to an endovascular simulator with high face validity. We suggest that case rehearsal prior to an operation may be useful in the planning and execution of carotid artery intervention.

Contact:

Inbal Mazor

VP Marketing

Simbionix

mailto: inbal@simbionix.com

http://www.simbionix.com

Tel: +1-216-229-2040


'/>"/>
SOURCE Simbionix Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
2. Physicians Health Study II Finds No Magic Bullet for Preventing Cardiovascular Disease
3. Atrial Fibrillation Found to be Common in Patients With Atherothrombosis, Increases Risk of Cardiovascular Death, Heart Attack and Stroke
4. Tackling Atrial Fibrillation and Associated Cardiovascular Risk
5. XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week
6. Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation
7. Data Confirm Synvista Therapeutics Haptoglobin Diagnostic Test Kit Success in Rapidly Determining Cardiovascular Risk in Patients with Diabetes
8. Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa
9. Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel
10. Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events
11. ViaViente Demonstrates Cardiovascular Benefits in New Human Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... April 28, 2016 New ... 2016" is a report that provides an overview ... R&D pipelines by identifying new targets and MOAs ... Company Profiles discussed in this H1 2016 Osteoarthritis ... Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx NV, ...
(Date:4/27/2016)... BASEL , Schweiz, April 27, 2016 ... des Sachs CEO Forums in Zürich ... Phase-II-Studie ihres führenden Wirkstoffkandidaten STR001 zur Erhaltung ... (CI) eingesetzt wurde, bekannt. Für die umfassende ... Deutschland und Frankreich angeworben. STR001 wird während ...
(Date:4/27/2016)... 2016   , ... Recurring Consumable Sales  Clinical sales grow 16% ... (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... the first quarter ended March 31, 2016 and provided ... its commercial strategy. First Quarter 2016 Revenue ...
Breaking Medicine Technology:
(Date:5/2/2016)... and Shelton, CT (PRWEB) , ... May 02, 2016 , ... ... President and Owner of New England Low Vision and Blindness (NELV&B) , announces ... add more flexibility and convenience for people with vision impairments to get assessments, hands-on ...
(Date:5/1/2016)... ... May 01, 2016 , ... ... that gives new mothers a better understanding of what to expect after they ... Adjusting to baby postpartum, · The blues and depression, · Breastfeeding beyond postpartum ...
(Date:4/30/2016)... ... April 30, 2016 , ... Create ... Abstract users can distort and manipulate three-dimensional shapes with ease all within ... ranks, point, lines, polygons, polygon texture animation, opacity texture animation, overall shape texture ...
(Date:4/30/2016)... , ... April 30, 2016 ... ... CBC News on April 4th, 2016 questioned the use of the HyProCure ... EOTTS-HyProCure as “a controversial procedure.” EOTTS-HyProCure is a minimally invasive procedure performed, ...
(Date:4/29/2016)... ... April 29, 2016 , ... In an article published ... her enthusiasm for Botox and lip injections, which she underwent in order to feel ... Valley Music and Arts Festival. The article explains that Ms. Mirmelli’s situation is not ...
Breaking Medicine News(10 mins):